DOI: 10.36347/sasjm.2022.v08i01.006

Pages: 24-27

Pulmonary hypertension (PH) is a complex, chronic and a challenging condition that can be associated with several cardiac, pulmonary, and systemic diseases contributing to morbidity and mortality. Treating PH is multifaceted and concentrates on treatment of the underlying disorder, with referral to expert PH centres for individual assessment and tailored therapy. Targeted pharmacological and surgical treatments are available for patients with PH, for whom early referral to a specialist PH centre is recommended. Recent advancements in PH-targeted therapies and interventional-surgical procedures have contributed to the improvement in quality of life and survival in PH. This article gives an update on recent developments in the management of PH.